Other public bodies · Sub-organisation. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.
Reports
2
Naming this recipient
Published responses
100%
Found for named reports
Concerns addressed
2
Across all linked responses
Stated actions
7
Described in responses
Reports over time
Reports over time
Reports naming this recipient by issue year.
Evidence profile
Report topics
Share of this recipient’s reports compared with all other recipients.
100%published responses found
7stated actions described
Topic comparisons are not available in the current evidence snapshot.
Concerns and recipient responses
Statements from National Ambulance Resilience Unit linked to the concerns in each report. Select any concern, action or position to view the source wording.
Buckinghamshire
Concerns raised2
Lack of ambulance carriage of appropriate antidote medication for on-scene administration
Failure of ambulance triage and prioritisation to provide sufficient time for emergency treatment
Responses linked to these concerns
Each statement is shown once, even when linked to more than one concern.
Actions described in response An action is something this recipient says it has done, is doing, or plans to do in response to the concern raised.2
Action
Convene the September Clinical Subgroup to discuss toxicological incidents, methylene blue, methaemoglobinaemia management, and potential expansion of HART carriage or trial activity.
Stated plannedThe respondent said that this action was planned when they made their response on 14 June 2024.
Action
Collate evidence from HART experience and subject-matter experts, then present a report to NASMeD for consideration and review by NASMeD and AACE/JRCALC.
Stated plannedThe respondent said that this action was planned when they made their response on 14 June 2024.
Respondent positions A position is what this recipient says about the concern when it does not describe a specific action.4
Position
Each ambulance Trust, authorised by its Executive Medical Director and Chief Pharmacist, decides which drugs its ambulances carry.
Redirects responsibilityThe respondent said that another organisation was responsible for deciding or taking action.
Position
Equipping every ambulance with methylene blue may be prohibitively costly and create substantial storage, equipment and training burdens.
Unable to actThe respondent said that a constraint prevented them from taking the relevant action.
Position
Mandating methylene blue carriage on frontline ambulances is outside NARU’s authority.
Outside remitThe respondent said that this matter was outside its role or authority.
Position
NARU cannot provide guidance on HART carriage until incidence, benefits and costs are better understood through further evidence.
Unable to actThe respondent said that a constraint prevented them from taking the relevant action.
Manchester South
Concerns raised1
Ambiguity in staffing-level guidance for medical-area resources at events
Responses linked to these concerns
Each statement is shown once, even when linked to more than one concern.
Actions described in response An action is something this recipient says it has done, is doing, or plans to do in response to the concern raised.3
Action
Make necessary changes to the guidance following stakeholder consultation.
Stated plannedThe respondent said that this action was planned when they made their response on 29 July 2019.
Action
Draft amendments to clarify emergency-plan guidance and address the report’s specific concerns.
Stated completedThe respondent said that this action was complete when they made their response on 29 July 2019.
Action
Complete a national review of emergency-plan guidance, including Annex B provisions.
Stated completedThe respondent said that this action was complete when they made their response on 29 July 2019.
Pin
Request correction
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations